Raymond James & Associates’s Gentex GNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $19.7M | Buy |
663,302
+12,418
| +2% | +$386K | 0.01% | 826 |
|
|
2024
Q2 | $21.9M | Buy |
650,884
+77,816
| +14% | +$2.69M | 0.01% | 732 |
|
|
2024
Q1 | $20.7M | Buy |
573,068
+9,550
| +2% | +$330K | 0.01% | 763 |
|
|
2023
Q4 | $18.4M | Buy |
563,518
+2,234
| +0.4% | +$69K | 0.01% | 780 |
|
|
2023
Q3 | $18.3M | Buy |
561,284
+14,596
| +3% | +$468K | 0.02% | 722 |
|
|
2023
Q2 | $16M | Buy |
546,688
+213,785
| +64% | +$5.89M | 0.01% | 811 |
|
|
2023
Q1 | $9.33M | Buy |
332,903
+49,470
| +17% | +$1.39M | 0.01% | 1067 |
|
|
2022
Q4 | $7.73M | Sell |
283,433
-3,795
| -1% | -$101K | 0.01% | 1152 |
|
|
2022
Q3 | $6.85M | Buy |
287,228
+15,625
| +6% | +$429K | 0.01% | 1170 |
|
|
2022
Q2 | $7.6M | Buy |
271,603
+24,406
| +10% | +$710K | 0.01% | 1137 |
|
|
2022
Q1 | $7.21M | Sell |
247,197
-37,895
| -13% | -$1.18M | 0.01% | 1253 |
|
|
2021
Q4 | $9.94M | Buy |
285,092
+38,253
| +15% | +$1.36M | 0.01% | 1112 |
|
|
2021
Q3 | $8.14M | Sell |
246,839
-11,205
| -4% | -$362K | 0.01% | 1179 |
|
|
2021
Q2 | $8.54M | Buy |
258,044
+14,763
| +6% | +$512K | 0.01% | 1162 |
|
|
2021
Q1 | $8.68M | Sell |
243,281
-4,061
| -2% | -$144K | 0.01% | 1108 |
|
|
2020
Q4 | $8.39M | Buy |
247,342
+2,602
| +1% | +$80.2K | 0.01% | 1051 |
|
|
2020
Q3 | $6.3M | Sell |
244,740
-27,108
| -10% | -$720K | 0.01% | 1102 |
|
|
2020
Q2 | $7.01M | Sell |
271,848
-23,651
| -8% | -$593K | 0.01% | 1005 |
|
|
2020
Q1 | $6.55M | Buy |
295,499
+75,093
| +34% | +$2.09M | 0.01% | 922 |
|
|
2019
Q4 | $6.39M | Buy |
220,406
+1,208
| +0.6% | +$34K | 0.01% | 1114 |
|
|
2019
Q3 | $6.04M | Sell |
219,198
-42,889
| -16% | -$1.13M | 0.01% | 1119 |
|
|
2019
Q2 | $6.45M | Sell |
262,087
-15,051
| -5% | -$341K | 0.01% | 1087 |
|
|
2019
Q1 | $5.73M | Buy |
277,138
+92,042
| +50% | +$1.92M | 0.01% | 1113 |
|
|
2018
Q4 | $3.74M | Sell |
185,096
-14,015
| -7% | -$294K | 0.01% | 1243 |
|
|
2018
Q3 | $4.27M | Buy |
199,111
+20,376
| +11% | +$471K | 0.01% | 1312 |
|
|
2018
Q2 | $4.11M | Buy |
178,735
+51,673
| +41% | +$1.23M | 0.01% | 1317 |
|
|
2018
Q1 | $2.92M | Sell |
127,062
-577
| -0.5% | -$13.1K | 0.01% | 1458 |
|
|
2017
Q4 | $2.67M | Buy |
127,639
+7,982
| +7% | +$159K | ﹤0.01% | 1501 |
|
|
2017
Q3 | $2.37M | Buy |
119,657
+68,041
| +132% | +$1.24M | ﹤0.01% | 1533 |
|
|
2017
Q2 | $979K | Sell |
51,616
-81,989
| -61% | -$1.6M | ﹤0.01% | 2038 |
|
|
2017
Q1 | $2.85M | Sell |
133,605
-8,728
| -6% | -$183K | 0.01% | 1330 |
|
|
2016
Q4 | $2.8M | Sell |
142,333
-2,640
| -2% | -$48.1K | 0.01% | 1286 |
|
|
2016
Q3 | $2.55M | Buy |
144,973
+87,480
| +152% | +$1.51M | 0.01% | 1313 |
|
|
2016
Q2 | $888K | Buy |
57,493
+10,726
| +23% | +$170K | ﹤0.01% | 1800 |
|
|
2016
Q1 | $734K | Sell |
46,767
-12,358
| -21% | -$180K | ﹤0.01% | 1834 |
|
|
2015
Q4 | $947K | Sell |
59,125
-2,206
| -4% | -$35.6K | ﹤0.01% | 1662 |
|
|
2015
Q3 | $951K | Buy |
61,331
+6,263
| +11% | +$99.5K | ﹤0.01% | 1620 |
|
|
2015
Q2 | $904K | Sell |
55,068
-86,694
| -61% | -$1.52M | ﹤0.01% | 1788 |
|
|
2015
Q1 | $2.59M | Sell |
141,762
-12,596
| -8% | -$222K | 0.01% | 1094 |
|
|
2014
Q4 | $2.79M | Buy |
+154,358
| New | +$2.56M | 0.01% | 981 |
|
|
2013
Q3 | – | Sell |
-45,454
| Closed | -$524K | – | 1930 |
|
|
2013
Q2 | $524K | Buy |
+45,454
| New | +$512K | ﹤0.01% | 1501 |
|
Other funds holding GNTX
EIG
AI
BGC
BAM
Raymond James & Associates's GNTX Position: Q3 2024 in Review
Raymond James & Associates increased its Gentex (GNTX) stake by 1.9% in Q3 2024, buying an estimated $386K and bringing the position to 663,302 shares worth $19.7M. The position accounts for 0.01% of the portfolio, ranked #826.
Raymond James & Associates first reported a position in GNTX in Q2 2013 and has held it in 41 quarters since. The position peaked at $21.9M in Q2 2024. 525 funds tracked by Wall St. Rank hold GNTX as of Q3 2024.
- Raymond James & Associates held 663,302 shares of Gentex worth $19.7M as of Q3 2024.
- Raymond James & Associates bought 12,418 Gentex shares in Q3 2024, an estimated $386K.
- Gentex made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #826 holding.
- Raymond James & Associates first reported a position in Gentex in Q2 2013 and has held it in 41 quarters since.
- Raymond James & Associates's Gentex position peaked at $21.9M in Q2 2024.
- 525 funds tracked by Wall St. Rank held Gentex as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.